OC Ventures

We advised Riverlane, the global leader in quantum error correction (QEC) technology, on its US$75 million Series C funding round to deliver its QEC roadmap, expanding operations and setting-out a plan to achieve one million error-free quantum computer operations by 2026.

We advised Albion Capital on fintech Kennek Solutions £10m funding round. Other investors included HV Capital, Dutch Founders Fund, FFVC, Plug & Play Ventures and Syndicate One.

We advised StudentCrowd, a decision-making platform for higher education, on its Series A fundraising round led by Mercia Ventures.

We advised AlbionVC and Delin Ventures on their investment in health and research technology company uMed's £9.8 million Series A funding round.
 

We advised financial services-focused venture firm Illuminate Financial on the final close of its third fund, a $235 million fund to invest in early-stage businesses solving problems for financial institutions.

We advised Mera Investment Management ("Mera IM"), a specialist real estate lender, as it secures significant equity backing from a private family office to accelerate its growth plans and future lending ambitions. The investment will see Mera IM look to deploy some £100m of lending this year. 

We advised Fintern on Abound's £500m funding to accelerate growth of affordable loans. 

We advised Flock  the London-based insurance technology company that uses real-time data to enable and incentivise safer driving, on a $38M series B fundraising led by Octopus Ventures, one of the largest and most active venture capital investors in Europe. 

We advised AlbionVC as the world's first cybersecurity human risk management platform, OutThink, which combines machine learning, natural language processing and applied psychology to identify individuals' attitudes and behaviours, has raised £8.8 million in its latest funding round. 
 

We advised Argonaut Therapeutics Ltd on its merger with Celleron Therapeutics Ltd. 
 

We advised Foresight, a leading listed regional private equity and infrastructure investment manager, on the first close of its Foresight Scotland Fund.

We advised UCL Technology Fund on lead investment in Bloomsbury Genetic Therapies' £5 million financing round.

We advised BGF on its investment in autonomous vehicle software global leader Oxbotica's Series C funding round raising US$140 million. The funding will be used to drive Oxbotica's global expansion and accelerate commercialisation of its technology.